Skip to main content

Table 4 Cost-effectiveness ratio in US $, 2008-dated [equivalent US $, 2017-dated] for one-dose and two-dose varicella vaccine in Colombia [64]

From: Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review

Cost

One-Dose Vaccine Compared With No Vaccine

(ACER)

Two-Dose Vaccine Compared With No Vaccine

(ACER)

Two-Dose Vaccine Compared With One-Dose Vaccine

(ICER)

Cost per avoided consultation

$9 (equivalent to $12.5)

$21 (equivalent to $29.2)

$119 (equivalent to $165.4)

Cost per avoided hospitalization

$4893 (equivalent to $5681.9)

$11,127 (equivalent to $11,5463.7)

$64,110 (equivalent to $89,096.7)

Cost per avoided death

$75,187 (equivalent to $87,309.1)

$170,962 (equivalent to $237,594.0)

$983,977 (equivalent to $1,367,479.3)

Cost per LYG

$2519 (equivalent to $3318.76)

$5728 (equivalent to $6305.69)

$33,002 (equivalent to $43,479.91)

Cost per DALY averted

$1362 (equivalent to $1892.8)

$3097 (equivalent to $4304.1)

$17,844 (equivalent to $24,798.7)

  1. ACER average cost-effectiveness ratio; DALY disability adjusted life-years; ICER incremental cost-effectiveness ratio; LYG life-years gained